Photo of Ryan Panchadsaram
Taken by Stephen Voss

Ryan Panchadsaram

At Kleiner Perkins, I focus on venture-stage companies and serve as advisor to the Chair, John Doerr. Together we invest in bold founders and disruptive technologies.

I am an investor in ASAPP, Grammarly, Mos, Natalist, SpinLaunch, Tia, Tempus, Trialspark, and Visby. I also work with companies and brands: Biossance, Bloom Energy, Coursera, Fin, Nuna, and Remind.

In 2018, John and I launched to support and inspire leaders to set and achieve their most audacious goals.

Formerly, I was the Deputy Chief Technology Officer for the United States. At the White House, our team spent our days and nights ensuring America is the best place for engineers, entrepreneurs, and innovators.

We helped shape how an $80 billion IT budget can be used by federal agencies to deliver on their missions in a more effective, design-centric, and data-driven way. We defined a new way to operate and we launched the U.S. Digital Service. We implemented the Open Data Executive Order and re-launched which now has over 180,000 datasets.

In 2015, I served as a delegate to the United Nations, where we launched the Solutions Summit, a grassroots effort to lift-up and progress the work of exceptional innovators around the world tackling the Sustainable Development Goals. We also supported the State Department's Global Connect Initiaive which aims to bring an additional 1.5 billion people who lack Internet access online by 2020.

In 2014, during the Ebola virus epidemic, I led a team that coordinated data requests between governments, international aid organizations, the private sector, and volunteers supporting the response in West Africa.

In 2013, I was part the crisis response team that rescued Helping rescue the site was a multi-month effort that ultimately enrolled millions people into affordable health coverage.

Prior to public service, I co-founded Pipette, a healthcare startup focused on reducing the number of complications and unplanned readmissions after surgeries. We were using mobile technologies to improve patient care and reduce overall health spending. Our company was a proud product of Rock Health.

On March 2012, Pipette was acquired by, a MIT Media Lab spinoff that uses big-data from mobile phones, machine learning, and statistical pattern matching to improve the world's health.

I've previously worked in product roles at Microsoft and At Microsoft, I was responsible for the user experience and design for Outlook for Mac 2011 and filed multiple patents for innovations in geolocation, user interfaces, and large datasets. I currently sit on the editorial board of the Big Data Journal.